Within each indication, except nephroblastoma, cases with the highest levels of PD‐L1 did not correlate with highest TIL marker levels (Type III paradigm; 17), suggesting that PD‐L1 and TIL markers may not follow the same immunobiology in these indications. The gene discussed is CD274; the disease is Wilms tumor.